Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06666426 · ClinicalTrials.gov registry record · NA

This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.

A NA study, sponsored by C. R. Bard.

Completed
Registry status
NA
Development phase
171
Enrollment target

NCT06666426: Completed NA study, sponsored by C. R. Bard.

NCT06666426 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 171 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06666426, a NA study, has completed, sponsored by C. R. Bard.

COMPLETED
Registry status
NA
Development phase
171 participants
Enrollment target

Study Summary

This post-market study will assess the performance of and user experience with the PureWick™ System in a home setting. The study will also observe safety of the study device and collect information from participants about their quality of life before and after using the device.

Primary Outcome

Daily capture rate (captured as % of urine captured by device and collected in canister, measured by weight)

Interventions

  • DEVICE PureWick System
  • DEVICE Hollister Female Urinary Pouch External Collection Device

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2024-10-31
Est. Completion 2025-06-30
Phase NA
C. R. Bard

75 total trials

What the finished NCT06666426 record still lists

NCT06666426 is an interventional study that assigns participants to a tested intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 2 interventions - of which PureWick System is the first listed.

NCT06666426 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06666426 about?

NCT06666426 is a clinical study titled "This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.". This post-market study will assess the performance of and user experience with the PureWick™ System in a home setting. The study will also observe safety of the study device and collect information from participants about their quality of life before and after using the device.

What is the current status of trial NCT06666426?

This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2024-10-31. Estimated completion is 2025-06-30.

What interventions are being tested in trial NCT06666426?

The interventions under investigation include: PureWick System (DEVICE), Hollister Female Urinary Pouch External Collection Device (DEVICE).

Who is sponsoring clinical trial NCT06666426?

This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06666426's enrollment target sits among peer trials

171 612th of 2000 higher than 1,387 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02641145 · 171 participants · NA

    Molecular Imaging of Primary Amyloid Cardiomyopathy

  • NCT05541029 · 171 participants · NA

    Music Listening: A Mechanistic Trial

  • NCT05561127 · 171 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

  • NCT05592938 · 171 participants · NA

    Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06666426, the US trial registry maintained by the National Library of Medicine. NCT06666426 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.